NCT07069738 - Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure | Biotech Hunter

Enrollment

850

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

November 30, 2029

Study Completion Date

November 30, 2029

Conditions

Heart Failure - NYHA II - IV

Interventions

DEVICE

CRT-D with a Quadripolar LV lead

Participants randomized to this cohort will receive a BSC system: CRT-D, Right Atrial Lead (RA), Defibrillation Lead (RV), Quadripolar LV Lead.

DEVICE

CRT-D with INGEVITY+ pace/sense lead

Participants randomized to this cohort will receive a BSC system: CRT-D, Right Atrial Lead (RA), Defibrillation Lead (RV), INGEVITY+ pace/sense Lead (implanted in the LBBA)